Abstract
We have read the perspective entitled “How-to-guide for medication reviews in older adults with cancer: A Young International Society of Geriatric Oncology and Nursing & Allied Health Group initiative” with great enthusiasm [1]. Authors pointed out that older adults with cancer are at increased risk of and should be assessed for polypharmacy and/or potentially inappropriate medication use (PIM). They recommended that when polypharmacy and/or PIM is encountered, preferably a multidisciplinary team should perform a medication review (MR) in order to avoid treatment related harms and ensure that the benefit of treatments outweigh the risks.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
